Association between diffuse lymphocytic infiltration and papillary thyroid cancer aggressiveness according to the presence of thyroid peroxidase antibody and BRAFV600E mutation

被引:15
作者
Lee, Young Ki [1 ]
Park, Kyeong Hye [2 ,3 ]
Park, Se Hee [1 ]
Kim, Kwang Joon [4 ]
Shin, Dong Yeob [1 ]
Nam, Kee Hyun [5 ]
Chung, Woong Youn [5 ]
Lee, Eun Jig [1 ]
机构
[1] Yonsei Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, 50-1 Yonsei Ro, Seoul 03722, South Korea
[2] Ilsan Hosp, Natl Hlth Insurance Serv, Dept Internal Med, Div Endocrinol & Metab, Goyang, Gyeonggi, South Korea
[3] Yonsei Univ, Grad Sch Med, Seoul, South Korea
[4] Yonsei Univ, Coll Med, Dept Internal Med, Div Geriatr, Seoul, South Korea
[5] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2018年 / 40卷 / 10期
关键词
B-type Raf (BRAF); diffuse lymphocytic infiltration; Hashimoto's thyroiditis; papillary thyroid carcinoma; thyroid peroxidase antibody; HASHIMOTOS-THYROIDITIS; CARCINOMA; METAANALYSIS; EXPRESSION; FEATURES; KOREA; GENE; P63;
D O I
10.1002/hed.25327
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background Diffuse lymphocytic infiltration (DLI) is frequently found with papillary thyroid cancer (PTC), so there has been long interest in how it affects the characteristics of PTC. This purpose of this study was to define the association between DLI and PTC aggressiveness according to thyroperoxidase antibody (TPOAb) and B-type Raf (BRAF)(V600E) mutation positivity. MethodsResultsThere were 1879 patients with PTC who underwent surgery and were enrolled in this study. Clinicopathologic characteristics were compared between groups according to the presence of DLI and TPOAb. Multiple logistic regression analysis was conducted to assess odds ratio (OR) for each dependent variable (BRAF(V600E) mutation, tumor size >1.0 cm, multifocality, extrathyroidal extension, and lymph node metastasis) of each group according to the presence of DLI and TPOAb, with the group with neither DLI or TPOAb (DLI-negative TPOAb-negative PTC) as the reference. The DLI-positive PTC showed more frequent multifocality and less frequent BRAF(V600E) mutation than DLI-negative PTC. Among patients with DLI-positive PTC, extrathyroidal extension and BRAF(V600E) mutation was less frequent when serum TPOAb was positive. In multiple logistic regressions, DLI-positive TPOAb-positive PTC showed a high OR for multifocality (1.410; P = .017), but low ORs for BRAF(V600E) mutation (0.521; P < .001) and extrathyroidal extension (0.691; P = .008). The patients with DLI-positive TPOAb-positive PTCs showed a high OR for multifocality (1.588; P = .002), and high ORs for tumor size >1.0 cm (2.205; P = .019) and lymph node metastasis (2.005; P = .032) in subgroup analyses of PTC with wild-type BRAF. The DLI-negative TPOAb-positive group was not associated with any tumor aggressiveness-related variables. ConclusionAlthough DLI was associated with multifocality regardless of TPOAb positivity, it was associated with an indolent feature when TPOAb was positive but with aggressive features in PTC with wild-type BRAF when TPOAb was negative. The TPOAb and BRAF status may help to define the clinical implication of lymphocytic infiltration found with PTC.
引用
收藏
页码:2271 / 2279
页数:9
相关论文
共 50 条
[31]   Morphological features predictive for BRAFV600E mutation in papillary thyroid microcarcinomas [J].
Nechifor-Boila, Adela Corina ;
Szasz, Emoke-Andrea ;
Descotes, Francoise ;
Berger, Nicole ;
Zahan, Ancuta Elena ;
Loghin, Andrada ;
Ceteras, Delia Maria ;
Borda, Angela .
ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2018, 59 (03) :747-753
[32]   BRAFV600E Mutation in Papillary Thyroid Carcinoma: Significant Association with Node Metastases and Extra Thyroidal Invasion [J].
Chakraborty, Avik ;
Narkar, Archana ;
Mukhopadhyaya, Rita ;
Kane, Shubhada ;
D'Cruz, Anil ;
Rajan, M. G. R. .
ENDOCRINE PATHOLOGY, 2012, 23 (02) :83-93
[33]   BRAFV600E Overrides NOTCH Signaling in Thyroid Cancer [J].
Traversi, Florian ;
Stooss, Amandine ;
Dettmer, Matthias S. ;
Charles, Roch-Philippe .
THYROID, 2021, 31 (05) :787-799
[34]   The BRAFV600E mutation in papillary thyroid microcarcinoma: does the mutation have an impact on clinical outcome? [J].
Walczyk, Agnieszka ;
Kowalska, Aldona ;
Kowalik, Artur ;
Sygut, Jacek ;
Wypiorkiewicz, Elzbieta ;
Chodurska, Renata ;
Pieciak, Liliana ;
Gozdz, Stanislaw .
CLINICAL ENDOCRINOLOGY, 2014, 80 (06) :899-904
[35]   Thyroid fine needle aspiration, the Bethesda System and the BRAFV600E mutation in Papillary Thyroid Carcinoma. Association and prediction for biopsy [J].
Galan-Garcia, Maria Eugenia ;
Martinez-Martin, Maria Soledad ;
Araujo-Ruano, Eduardo Jose ;
Loro-Ferrer, Juan Francisco ;
Saavedra-Santana, Pedro ;
Salido-Ruiz, Eduardo ;
Cabrera-Galvan, Juan Jose .
ACTA CYTOLOGICA, 2023, 67 (04) :346-356
[36]   Artificial intelligence to predict the BRAFV600E mutation in patients with thyroid cancer [J].
Yoon, Jiyoung ;
Lee, Eunjung ;
Koo, Ja Seung ;
Yoon, Jung Hyun ;
Nam, Kee-Hyun ;
Lee, Jandee ;
Jo, Young Suk ;
Moon, Hee Jung ;
Park, Vivian Youngjean ;
Kwak, Jin Young .
PLOS ONE, 2020, 15 (11)
[37]   Association between BRAFV600E mutation and the clinicopathological features in incidental papillary thyroid microcarcinoma: A single-center study in Turkish patients [J].
Sezer, Havva ;
Uren, Nihal ;
Yazici, Dilek .
NORTHERN CLINICS OF ISTANBUL, 2020, 7 (04) :321-328
[38]   Association between the BRAFV600E mutation and ultrasonographic features in papillary thyroid carcinoma: a study of 131 Chinese cases [J].
Zhang, Zheng ;
Zhao, Shuang-Shuang ;
Ding, Wen-Bo ;
Zhang, Xin ;
Wu, Xin-Cai ;
Du, Rui ;
Shang, Meng-Yuan ;
Chen, Zhe-Ming ;
Yu, Zhuan ;
Chen, Bao-Ding .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (02) :1929-1935
[39]   Oestrogen receptor alpha in papillary thyroid carcinoma: association with clinical features and BRAFV600E mutation [J].
Liu, Shiyang ;
Jiao, Bo ;
Li, Shuyu ;
Zhao, Lu ;
Zheng, Weihong ;
Wang, Kun ;
Xu, Jing ;
Tian, Yao ;
Liu, Chenguang ;
Gui, Zhengwei ;
Zhang, Lin .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (07) :1051-1058
[40]   The BRAFV600E mutation: what is it really orchestrating in thyroid cancer? [J].
Nucera, Carmelo ;
Lawler, Jack ;
Hodin, Richard ;
Parangi, Sareh .
ONCOTARGET, 2010, 1 (08) :751-756